Control of Redox Homeostasis by Short-Chain Fatty Acids: Implications for the Prevention and Treatment of Breast Cancer
Open Access
Abstract
Breast cancer is the leading cause of death among women worldwide, and certain subtypes are highly aggressive and drug resistant. As oxidative stress is linked to the onset and progression of cancer, new alternative therapies, based on plant-derived compounds that activate signaling pathways involved in the maintenance of cellular redox homeostasis, have received increasing interest. Among the bioactive dietary compounds considered for cancer prevention and treatment are flavonoids, such as quercetin, carotenoids, such as lycopene, polyphenols, such as resveratrol and stilbenes, and isothiocyanates, such as sulforaphane. In healthy cells, these bioactive phytochemicals exhibit antioxidant, anti-apoptotic and anti-inflammatory properties through intracellular signaling pathways and epigenetic regulation. Short-chain fatty acids (SCFAs), produced by intestinal microbiota and obtained from the diet, also exhibit anti-inflammatory and anti-proliferative properties related to their redox signaling activity—and are thus key for cell homeostasis. There is evidence supporting an antioxidant role for SCFAs, mainly butyrate, as modulators of Nrf2-Keap1 signaling involving the inhibition of histone deacetylases (HDACs) and/or Nrf2 nuclear translocation. Incorporation of SCFAs in nutritional and pharmacological interventions changes the composition of the the intestinal microbiota, which has been shown to be relevant for cancer prevention and treatment. In this review, we focused on the antioxidant properties of SCFAs and their impact on cancer development and treatment, with special emphasis on breast cancer.Keywords
Funding Information
- Heart Research UK (RG2672, FS/15/6/31298, PRX19/00247)
- British Heart Foundation (RG2672, FS/15/6/31298, PRX19/00247)
- Medical Research Council (RG2672, FS/15/6/31298, PRX19/00247)
- Evgen Pharma (RG2672, FS/15/6/31298, PRX19/00247)
- Spanish Ministry of Science, Innovation and Universities (RG2672, FS/15/6/31298, PRX19/00247)
This publication has 131 references indexed in Scilit:
- Mutant p53: one name, many proteinsGenes & Development, 2012
- Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, ChinaCarcinogenesis, 2011
- Sulforaphane inhibits the growth of KPL-1 human breast cancer cells in vitro and suppresses the growth and metastasis of orthotopically transplanted KPL-1 cells in female athymic miceOncology Reports, 2011
- Dietary isoflavones and vascular protection: Activation of cellular antioxidant defenses by SERMs or hormesis?Molecular Aspects of Medicine, 2010
- Oxidative stress, inflammation, and cancer: How are they linked?Free Radical Biology and Medicine, 2010
- Deconstructing the molecular portraits of breast cancerMolecular Oncology, 2010
- Histone Deacetylase Inhibitors in Cancer TherapyJournal of Clinical Oncology, 2009
- Structure activity relationship of carotenoid derivatives in activation of the electrophile/antioxidant response element transcription systemFree Radical Biology and Medicine, 2009
- The role of histone deacetylases (HDACs) in human cancerMolecular Oncology, 2007
- Selection of a highly tumorigenic breast cancer cell line sensitive to estradiol to evidence in vivo the tumor-inhibitory effect of butyrate derivative monobut-3Life Sciences, 1994